DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Gadodiamide

Gadodiamide

  • ACR Manual on Contrast Media

    ACR Manual on Contrast Media

  • FDA Warns That Gadolinium-Based Contrast Agents (Gbcas) Are Retained in the Body; Requires New Class Warnings

    FDA Warns That Gadolinium-Based Contrast Agents (Gbcas) Are Retained in the Body; Requires New Class Warnings

  • Gadolinium Based Contrast Agents

    Gadolinium Based Contrast Agents

  • DISSERTATION INVESTIGATION of CATIONIC CONTRAST-ENHANCED COMPUTED TOMOGRAPHY for the EVALUATION of EQUINE ARTICULAR CARTILAGE Su

    DISSERTATION INVESTIGATION of CATIONIC CONTRAST-ENHANCED COMPUTED TOMOGRAPHY for the EVALUATION of EQUINE ARTICULAR CARTILAGE Su

  • Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017

    Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017

  • Estonian Statistics on Medicines 2016 1/41

    Estonian Statistics on Medicines 2016 1/41

  • Guideline on the Use of Gadolinium-Containing MRI Contrast Agents in Patients with Renal Impairment

    Guideline on the Use of Gadolinium-Containing MRI Contrast Agents in Patients with Renal Impairment

  • Art. 31 Gadolinium

    Art. 31 Gadolinium

  • Active Moiety Name FDA Established Pharmacologic Class (EPC) Text

    Active Moiety Name FDA Established Pharmacologic Class (EPC) Text

  • PART VI Summary of Activities in the Risk Management Plan by Product

    PART VI Summary of Activities in the Risk Management Plan by Product

  • Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO

    Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • EMA's Final Opinion Confirms Restrictions on Use of Linear

    EMA's Final Opinion Confirms Restrictions on Use of Linear

  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021

    FDA Listing of Established Pharmacologic Class Text Phrases January 2021

  • Chapter 1: Introduction and Background…………………………………………….…...1

    Chapter 1: Introduction and Background…………………………………………….…...1

  • Gadolinium Containing Contrast Agents

    Gadolinium Containing Contrast Agents

  • Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: the Physio-Pathological Conditions for the Perfect Murder

    Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: the Physio-Pathological Conditions for the Perfect Murder

  • Manual on Contrast Media Version 7 2010

    Manual on Contrast Media Version 7 2010

Top View
  • PRODUCT MONOGRAPH OMNISCAN (Gadodiamide Injection
  • Contrast Media Tutorial
  • Safety Evaluation of Linear and Macrocyclic Gadolinium-Based
  • Gadolinium Contrast Media Are More Nephrotoxic Than a Low Osmolar
  • ACR Manual on Contrast Media (2020)
  • Intrathecal Use of Gadobutrol for Glymphatic MR Imaging: Prospective Safety Study of 100 Patients
  • Biem Pharmaceuticals Is
  • Provisional Peer-Reviewed Toxicity Values for Stable (Nonradioactive) Gadolinium (Casrn 7440-54-2) and Soluble Salts
  • Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement
  • Gadolinium Containing Contrast Agents (Gdcas) Are Complexes of Paramagnetic Gadolinium (III) with Different Types of Organic Chelators
  • Viewed in Detail Elsewhere [7–10]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
  • Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution
  • National Licensed Medicine List of Afghanistan
  • Questions & Answers Re NSF and Gadolinium, 26 June 2007
  • Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
  • GE Healthcare Omniscan™ (Gadodiamide)
  • Safety and Clinical Usefulness of Gadoteric Acid Including Post-Marketing Surveillance


© 2024 Docslib.org    Feedback